Dr. Hee-Won Yoo is the CEO and President of Bukwang Pharmaceutical Co., Ltd, an R&D-focused Korean pharmaceutical company. Since her inauguration, Bukwang has made successful and outstanding footprints especially for new drug development and bio-venture investment by leveraging her extensive experiences and devotion. Prior to her current CEO post, she was deeply involved in the multi-national development and registration of several new drugs in joint projects with US and Japan based corporations. She has extensive experiences in a Korean bio-venture environment, with roles covering the establishment of bio-venture and development of drug products to commercialization.
Hee-Won received her Ph.D in Medicinal Chemistry from the School of Pharmacy at Ewha Women’s University in Korea. She then carried out her postdoctoral training in Chemistry of Carcinogenesis Laboratory at NIH in the US.
Mr. Sun Ho Kim is a Sr. Managing Director for Manufacturing in Bukwang Pharmaceutical Co., Ltd.
He has been dedicated to quality control and manufacturing field since he joined Bukwang. Prior to joining the company, Mr. Kim had worked for prestigious pharmaceutical companies in Korea like Yuhan, SK Chemical and Daewong. Now, he has around 30 years experience in pharmaceutical industry. Mr. Kim is a licensed pharmacist.
He graduated from Sungkyunkwan University, majored in Pharmacy.
Eun Ju Kim has been an executive in Antrogen, Bukwang CNC and Bukwangmedica. While serving as an executive, she oversaw all aspects of our organization in terms of efficiency and effectiveness to meet business goals, provided strategic advice and guidance to keep others aware of developments within the industry and ensured that the appropriate policies were developed to meet the company’s mission and objectives and to comply with all relevant statutory and other regulations.
She majored in science education at Ewha Women’s University.